Literature DB >> 32186015

Classifying rheumatoid arthritis by Traditional Chinese Medicine Zheng: a multi-center cross-sectional study.

Weijie Wang1, Xinchang Wang1, Xiaopo Tang1, Quan Jiang2, Yongsheng Fan3.   

Abstract

OBJECTIVE: To assess the relationship between disease symptoms and traditional Chinese medicine (TCM) syndrome (Zheng) in rheumatoid arthritis (RA) patients.
METHODS: RA Patients were recruited in Guang'anmen Hospital, China Academy of Chinese Medical Sciences and in the Second Affiliated Hospital of Zhejiang Chinese Medical University, and diagnosed with a particular RA Zheng from their symptoms. Demographic characteristics, self-reported symptoms, and blood samples were collected from patients. All data were input into EpiData and analyzed using SPSS software.
RESULTS: The study included 302 RA patients (age range: 18-86 years). All patients were Chinese, and 85.1% were women. Cold and fatigue triggers were reported by 8.6% of patients, followed by triggers such as childbirth (4.3%), cold (3.0%), dampness (2.0%), menopause (1.3%), and psychentonia (0.7%). The most prevalent Zheng was dampness and heat blockage (Shire Yuzu in Chinese, SRYZ), diagnosed in 39.4% of patients (119), followed by phlegm and stagnation blockage (Tanyu Bizu, TYBZ) in 21.5%, liver and kidney deficiency (Ganshen Buzu, GSBZ) in 18.5%, dual deficiency of Qi and blood (Qixue Liangxu, QXLX) in 9.6%, cold and dampness blockage (Hanshi Bizu, HSBZ) in 6%, and wind and dampness blockage (Fengshi Bizu, FSBZ) in 5%. Increased length of time since RA diagnosis was associated with the GSBZ group. Patients diagnosed with the SRYZ Zheng had the highest disease activity score. Patients diagnosed with the QXLX Zheng had the lowest blood platelet counts; patients diagnosed with the QXLX and HSBZ Zhengs had lower C-reactive protein levels and lower health assessment questionnaire scores. Patients diagnosed with the GSBZ and QXLX Zhengs had the highest health assessment questionnaire scores.
CONCLUSION: The specific Zheng was related to RA characteristics. The findings suggest that eliminating dampness, cooling the patient, and promoting blood circulation may assist in treating severe RA.

Entities:  

Keywords:  Arthritis, rheumatoid; Cross-sectional studies; Symptoms and signs; Syndrome complex

Year:  2019        PMID: 32186015

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  6 in total

1.  Network Pharmacology Analysis and Experimental Validation to Investigate the Mechanism of Total Flavonoids of Rhizoma Drynariae in Treating Rheumatoid Arthritis.

Authors:  Guang-Yao Chen; Jing Luo; Yi Liu; Xin-Bo Yu; Xiao-Yu Liu; Qing-Wen Tao
Journal:  Drug Des Devel Ther       Date:  2022-06-08       Impact factor: 4.319

2.  Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis.

Authors:  Wenyang Wei; Wanpeng Lu; Xiaolong Chen; Yunfeng Yang; Mengkai Zheng
Journal:  Biomed Res Int       Date:  2021-08-10       Impact factor: 3.411

3.  Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine.

Authors:  Jijia Sun; Baocheng Liu; Ruirui Wang; Ying Yuan; Jianying Wang; Lei Zhang
Journal:  Dis Markers       Date:  2022-06-04       Impact factor: 3.464

4.  Wu-Teng-Gao External Treatment Improves Th17/Treg Balance in Rheumatoid Arthritis.

Authors:  Xueming Yao; Qiuyi Wang; Changming Chen; Ping Zeng; Lei Hou; Jing Zhou; Ying Huang; Wukai Ma
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-21       Impact factor: 2.629

5.  Traditional Chinese Medicine Is Associated with Reduced Risk of Readmission in Rheumatoid Arthritis Patients with Anemia: A Retrospective Cohort Study.

Authors:  Yanqiu Sun; Jian Liu; Ling Xin; Jianting Wen; Qin Zhou; Xiaolu Chen; Xiang Ding; Xianheng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

6.  The clinical efficacy of traditional Chinese medicine in the treatment of rheumatoid arthritis with interstitial lung disease: A protocol of systematic review and meta-analysis.

Authors:  Zhaoyi Liu; Jie Shen; Zhouli Shen; Dongyi He
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.